QURETECH BIO AB has a total of 25 patent applications. It increased the IP activity by 28.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are KING CLIFFORD RILEY, SPRUCE BIOSCIENCES INC and NANJING BAIJINGYU PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 4 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 1 | |
#9 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Almqvist Fredrik | 18 |
#2 | Good James Arthur Dudley | 15 |
#3 | Flentie Kelly | 9 |
#4 | Stallings Christina L | 9 |
#5 | Cairns Andrew Gerard | 6 |
#6 | Almqvist Klas Fredrik | 6 |
#7 | Stallings Christina Leigh | 5 |
#8 | Ponten Fritiof | 5 |
#9 | Sarkar Souvik | 5 |
#10 | Harrison Gregory Alexander | 5 |
Publication | Filing date | Title |
---|---|---|
EP3691619A1 | Ring-fused thiazolino 2-pyridones in combination with a drug against tuberculosis | |
EP3638681A1 | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | |
KR20180126511A | Ring-fused thiazolidino-2-pyridone, its preparation and its use in the treatment and / or prevention of tuberculosis | |
CN107074878A | 2,3 the thiazolines simultaneously ketone derivatives of [3,2 a] pyridine 5, its intermediate and its purposes as antibacterial agent | |
WO2014185853A1 | Compounds and methods for treatment of chlamydia infections |